Handa Pharmaceuticals, Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was TWD 28.859 million compared to TWD 84.070 million a year ago. Operating loss was TWD 317.478 million compared to TWD 204.940 million a year ago. Net loss was TWD 282.104 million compared to TWD 177.739 million a year ago. Basic loss per share was TWD 2.44 compared to TWD 1.62 a year ago.